Naohiro Fujimoto Selected Research

Naohiro Fujimoto Research Topics

Disease

51	Prostatic Neoplasms (Prostate Cancer) 06/2022 - 02/2002
25	Neoplasms (Cancer) 03/2022 - 02/2007
13	Carcinoma (Carcinomatosis) 10/2022 - 01/2015
7	Cystitis 12/2009 - 08/2004
5	Urinary Bladder Neoplasms (Bladder Cancer) 01/2020 - 02/2008
4	Urethritis 03/2022 - 10/2017
4	Neoplasm Metastasis (Metastasis) 01/2021 - 07/2013
3	Non-Muscle Invasive Bladder Neoplasms 03/2022 - 07/2020
3	Hyperthermia 01/2022 - 01/2015
3	Disease Progression 01/2022 - 03/2018
3	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 01/2020 - 11/2002
3	Lung Neoplasms (Lung Cancer) 07/2012 - 07/2012
3	Esophageal Neoplasms (Esophageal Cancer) 07/2012 - 07/2012
2	Renal Cell Carcinoma (Grawitz Tumor) 01/2022 - 01/2021
2	Hypersensitivity (Allergy) 05/2013 - 02/2007
2	Urinary Tract Infections (Urinary Tract Infection) 02/2011 - 11/2002
2	Inflammation (Inflammations) 04/2008 - 02/2005
2	Visceral Pain 02/2008 - 06/2007
1	Urologic Neoplasms (Urological Cancer) 10/2022
1	Retroperitoneal Fibrosis 06/2022
1	Pulmonary Eosinophilia (Eosinophilic Pneumonia) 01/2021
1	Pneumonia (Pneumonitis) 01/2021
1	Carcinogenesis 01/2020

Drug/Important Bio-Agent (IBA)

32	AndrogensIBA 02/2022 - 09/2004
15	Androgen Receptors (Androgen Receptor)IBA 11/2020 - 02/2002
7	Hormones (Hormone)IBA 02/2022 - 07/2006
7	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2009 - 08/2004
6	Biomarkers (Surrogate Marker)IBA 06/2022 - 07/2014
6	Prostate-Specific Antigen (Semenogelase)IBA 02/2022 - 06/2004
5	pembrolizumabIBA 10/2022 - 01/2021
5	enzalutamideIBA 06/2022 - 07/2013
5	Docetaxel (Taxotere)FDA Link 01/2021 - 11/2010
4	Messenger RNA (mRNA)IBA 07/2011 - 08/2004
3	PlatinumIBA 10/2022 - 09/2021
3	Pharmaceutical PreparationsIBA 01/2022 - 04/2008
3	Testosterone (Sustanon)FDA Link 11/2020 - 01/2018
3	Photosensitizing Agents (Photosensitizers)IBA 07/2012 - 07/2012
3	1-phenyl-3,3-dimethyltriazene (PDT)IBA 07/2012 - 07/2012
3	Proteins (Proteins, Gene)FDA Link 07/2011 - 10/2006
3	Corticotropin-Releasing HormoneIBA 06/2007 - 08/2004
2	abirateroneIBA 06/2022 - 01/2019
2	23S Ribosomal RNAIBA 03/2022 - 01/2018
2	DNA (Deoxyribonucleic Acid)IBA 02/2022 - 10/2021
2	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2021
2	CytokinesIBA 01/2022 - 05/2013
2	CarcinogensIBA 01/2021 - 01/2020
2	bicalutamide (Casodex)FDA LinkGeneric 11/2020 - 07/2013
2	Estrogens (Estrogen)FDA Link 01/2019 - 02/2005
2	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 01/2019 - 01/2018
2	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2018 - 07/2006
2	MacrolidesIBA 01/2018 - 01/2018
2	FluoroquinolonesIBA 01/2018 - 01/2018
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2016 - 02/2007
2	Zoledronic Acid (Zometa)FDA Link 09/2013 - 01/2012
2	Phosphates (Orthophosphate)IBA 12/2012 - 07/2006
2	Estramustine FDA Link 12/2012 - 07/2006
2	Adrenocorticotropic Hormone (ACTH)FDA Link 05/2006 - 08/2004
1	GlucocorticoidsIBA 06/2022
1	Immunoglobulin G (IgG)IBA 06/2022
1	Proton Pump InhibitorsIBA 03/2022
1	HLA-B Antigens (HLA-B)IBA 03/2022
1	HLA Antigens (Human Leukocyte Antigens)IBA 03/2022
1	compound 17IBA 01/2022
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2022
1	Circulating Tumor DNAIBA 11/2021
1	Cell-Free Nucleic AcidsIBA 11/2021
1	C-Reactive ProteinIBA 11/2021
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 10/2021
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 10/2021
1	cabazitaxel FDA Link 09/2021
1	Gemcitabine FDA Link 09/2021
1	Paclitaxel (Taxol)FDA LinkGeneric 09/2021
1	Therapeutic UsesIBA 04/2021
1	Glutathione PeroxidaseIBA 03/2021
1	NivolumabIBA 01/2021
1	Abiraterone AcetateIBA 01/2021
1	IpilimumabIBA 01/2021
1	Aldo-Keto ReductasesIBA 01/2020
1	naftopidilIBA 01/2020
1	Tamsulosin (Flomax)FDA LinkGeneric 01/2020
1	silodosin FDA Link 01/2020
1	Aromatase (CYP19)IBA 01/2019
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2019
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2019
1	Calcitriol Receptors (Calcitriol Receptor)IBA 01/2019
1	Estrogen ReceptorsIBA 01/2019

Therapy/Procedure

38	Therapeutics 06/2022 - 09/2004
31	Castration 06/2022 - 02/2005
8	Drug Therapy (Chemotherapy) 10/2022 - 02/2008
3	Immunotherapy 03/2022 - 01/2017
3	Cystectomy 09/2021 - 12/2017
3	Prostatectomy (Retropubic Prostatectomy) 01/2019 - 05/2011
3	Photochemotherapy (Photodynamic Therapy) 07/2012 - 07/2012
2	Intravesical Administration 03/2022 - 02/2008
2	Precision Medicine 02/2022 - 11/2021
2	Lymph Node Excision (Lymph Node Dissection) 01/2019 - 01/2019
2	Urinary Diversion (Ileal Conduit) 01/2018 - 06/2005
2	Radiotherapy 08/2015 - 01/2015
1	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 01/2022
1	Nephroureterectomy 01/2022